Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage.
作者信息
Traut Caroline C, Blankson Joel N
机构信息
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
出版信息
Lancet Microbe. 2023 Jun;4(6):e388. doi: 10.1016/S2666-5247(23)00105-2. Epub 2023 Mar 24.
Abstract
摘要
相似文献
1
Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage.二价mRNA疫苗引发的新冠病毒特异性T细胞可识别奥密克戎XBB亚谱系。
Lancet Microbe. 2023 Jun;4(6):e388. doi: 10.1016/S2666-5247(23)00105-2. Epub 2023 Mar 24.
2
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.早期估计，二价 mRNA 加强针在预防免疫功能正常成年人因奥密克戎 BA.5-和 XBB/XBB.1.5 相关亚谱系导致的有症状 SARS-CoV-2 感染方面的有效性-增加社区获得检测计划，美国，2022 年 12 月至 2023 年 1 月。
MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1.
3
BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer.BQ.1.1、XBB.1 和 XBB.1.5 对癌症患者二价 mRNA COVID-19 加强针的中和作用。
Cancer Cell. 2023 Apr 10;41(4):649-650. doi: 10.1016/j.ccell.2023.02.003. Epub 2023 Feb 9.
4
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论：奥密克戎 SARS-CoV-2 的 XBB.1.5（“Kraken”）亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
5
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.基于全基因组测序的奥密克戎变异株 BA.4 和 BA.5 对 SARS-CoV-2 检测 RT-qPCR 检测方法敏感性影响的计算机评估。
J Med Virol. 2023 Jan;95(1):e28241. doi: 10.1002/jmv.28241. Epub 2022 Nov 8.
6
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.养老院居民接种二价 COVID-19 疫苗后对原始 SARS-CoV-2 株和奥密克戎 BA.1 和 BA.4/BA.5 变异株的 SARS-CoV-2 抗体反应 - 俄亥俄州和罗得岛，2022 年 9 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):100-106. doi: 10.15585/mmwr.mm7204a4.
7
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.二价 mRNA 疫苗预防有症状的 SARS-CoV-2 感染的效果-增加社区获得检测的项目，美国，2022 年 9 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Dec 2;71(48):1526-1530. doi: 10.15585/mmwr.mm7148e1.
8
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.接种 COVID-19 mRNA 疫苗加强针对日本养老院队列中奥密克戎亚变种 BA.1 和 BA.5 的中和作用。
Vaccine. 2023 Mar 24;41(13):2234-2242. doi: 10.1016/j.vaccine.2023.02.068. Epub 2023 Feb 27.
9
T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.接种灭活疫苗第三针加强针后发生突变的奥密克戎刺突表位的 T 细胞反应。
J Med Virol. 2022 Aug;94(8):3998-4004. doi: 10.1002/jmv.27814. Epub 2022 May 6.
10
A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.第四针奥密克戎 RBD 疫苗加强了对 vaccinated mice 中 SARS-CoV-2 变异株（包括 BA.1 和 BA.2）的广泛中和作用。
J Med Virol. 2022 Aug;94(8):3992-3997. doi: 10.1002/jmv.27811. Epub 2022 May 6.
引用本文的文献
1
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells.XBB.1.5 mRNA加强疫苗不会显著增加XBB.1.5单反应性T细胞的百分比。
Front Immunol. 2025 Mar 12;16:1513175. doi: 10.3389/fimmu.2025.1513175. eCollection 2025.
2
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.一种二价新冠病毒mRNA疫苗引发了广泛的免疫反应并提供了针对奥密克戎亚变体感染的保护。
NPJ Vaccines. 2025 Jan 10;10(1):4. doi: 10.1038/s41541-025-01062-8.
3
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures.胃肠道癌患者中SARS-CoV-2疫苗接种与感染的纵向研究：通过适应性变异抗原暴露稳定免疫反应并中和新出现的变异株
Int J Mol Sci. 2024 Dec 19;25(24):13613. doi: 10.3390/ijms252413613.
4
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants.二价奥密克戎BA.1疫苗加强针可增加记忆B细胞广度以及针对新出现的新冠病毒变种的中和抗体。
EBioMedicine. 2024 Dec;110:105461. doi: 10.1016/j.ebiom.2024.105461. Epub 2024 Nov 28.
5
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.使用联合佐剂进行异源肌内mRNA初免/鼻内蛋白加强免疫后增强的黏膜严重急性呼吸综合征冠状病毒2免疫力
Mol Ther. 2024 Dec 4;32(12):4448-4466. doi: 10.1016/j.ymthe.2024.10.016. Epub 2024 Oct 28.
6
Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine.接种含BA.4/5的二价mRNA疫苗个体的血清对奥密克戎亚变体BN.1和XBB.1.5的中和活性较低。
Immune Netw. 2023 Nov 13;23(6):e43. doi: 10.4110/in.2023.23.e43. eCollection 2023 Dec.
Zotero 插件